$4.04
Price
$60M
Market Cap
—
P/E Ratio
28.9
Forward P/E
$-0.24
EPS (TTM)
—
Dividend Yield
$15M
Cash
$21M
Total Debt
15M
Shares Out
$1.85
$7.25
52-Week Range
Institutional Ownership of Cumberland Pharmaceuticals, Inc.
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Cumberland Pharmaceuticals, Inc.
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2021-Q3 | |||||
| SELL | EXIT | — | — | $2.91 | |
| 2021-Q2 | |||||
| SELL | -94.3% | 12.0K | $34000 | $2.96 | |
| 2021-Q1 | |||||
| SELL | -74.1% | 212.4K | $643000 | $3.25 | |
| 2020-Q4 | |||||
| BUY | +4.9% | 821.1K | $2M | $3.00 | |
| 2020-Q2 | |||||
| SELL | -27.8% | 782.4K | $3M | $3.64 | |
| 2020-Q1 | |||||
| BUY | +7.3% | 1.1M | $4M | $4.53 | |
| 2019-Q4 | |||||
| BUY | +5.4% | 1.0M | $5M | $5.30 | |
| 2019-Q3 | |||||
| SELL | -25.2% | 958.3K | $6M | $5.64 | |
| 2019-Q2 | |||||
| BUY | +6.8% | 1.3M | $8M | $6.13 | |
| 2019-Q1 | |||||
| BUY | +1.7% | 1.2M | $7M | $5.83 | |
| 2018-Q4 | |||||
| SELL | -8.6% | 1.2M | $7M | $6.03 | |
| 2018-Q3 | |||||
| SELL | -1.1% | 1.3M | $7M | $5.88 | |
| 2018-Q2 | |||||
| BUY | +28.7% | 1.3M | $8M | $6.16 | |
| 2018-Q1 | |||||
| BUY | +11.4% | 1.0M | $7M | $6.91 | |
Insider Trading for Cumberland Pharmaceuticals, Inc.
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.